Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
159 Cards in this Set
- Front
- Back
where is the auerbach's (myenteric) plexus?
|
between outer longitudinal and inner circular mm.
|
|
what is the major neurotransmitter in the myenteric and submucosal plexus?
|
Nitric Oxide
|
|
what do vagal signals affect?
|
stomach peristalsis, acid, panc acinar & HCO3 secretion, GB contraction,
minimal effect on small intestine |
|
what are the 3 major salivary glands?
|
paratid, submandibular, sublingual
|
|
what triggers saliva secretion?
|
both symp (T1-T3 sup. cervical gang) and parasymp (facial, glossopharyngeal)
|
|
what are the components of saliva?
|
alpha-amylase (digest starch)
bicarb (neutralize bact acid) mucin (glycoproteins, lubricate) |
|
where are parietal and chief cells found?
|
Fundis of stomach
|
|
name two GI hormone that belong to the same protein family
|
gastrin, CCK (identical C term, active region can bind each other's R)
|
|
what part of stomach is endocrine? exocrine?
|
endo: lower 1/3
exo: upper 2/3 (pepsin, HCl, IF etc) |
|
where is gastric produced?
|
G cells, antrum of stomach
|
|
Is NO a secretalogue or abs stimulant?
|
secretalogue
|
|
Is ACh a secretalogue or abs stimulant?
|
secretalogue
|
|
Is NE/Epi a secretalogue or abs stimulant?
|
stim. net abs
|
|
what is the action of gastrin?
|
in. H+ secretion, in. gastric mucosa
|
|
what regulates gastric production?
|
increased by:
stomach distention, aa (esp trp and phe), peptides, vagal stim, decreased by: H+ secretion, and stomach pH <1.5 |
|
what makes CCK (cholecytokinin)?
|
I cells of duodenum, jej.
|
|
what does CCK do?
|
1. in. panc. secretion
2. in. GB contraction 3. inhibits gastric emptying |
|
what triggers CCK production?
|
lumenal fat (C18>C16>C8) and aa from gastric chyme in duo (decreased by secretin and stomach pH < 1.5)
|
|
why in cholelithiasis, pain worsens after fatty food meal?
|
production of CCK -> squeezes GB
|
|
what makes secretin?
|
S cells of duodenum?
|
|
what does secretin do?
|
in. panc HCO3, inhibits gastric acid secretion
|
|
what triggers secretin production?
|
acid, fatty acids in duo lumen
|
|
what makes somatostatin?
|
D cells in pancreatic islet; GI mucosa
|
|
what does somatostatin do?
|
increases Na reabs
inhibits: 1. acid and pepsinogen secretion 2. panc. and small intestine fluid secretion 3. GB contraction 4. release of insulin/glucagon 5. de. gastrin, CCK, secretin, VIP, GIP |
|
what regulates somatostatin?
|
increased by acid;
inhibited by vagus |
|
what are octreotide, lanreotide?
|
long-lasting somatostatin mimic, for carcinoid syndrome (e.g. VIPoma)
|
|
what makes GIP (gastric inhibitory peptide)?
|
K cells in duo and jej
|
|
function of GIP?
|
exocrine: decrease H+ secretion and peristalsis
endocine: increase insulin release |
|
what do parietal cells secret?
|
intrinsic factor, gastric acid
|
|
what do chief cells secret?
|
pepsinogen, gastric lipase,
|
|
what happens when there's autoimmune destruction of parietal cells?
|
de. IF -> anemia
|
|
what triggers stomach acid production?
|
increase:
histamine, ACh, gastrin decrease: somatostatin, GIP, PGs |
|
what's the optimal pH for pepsin?
|
1-3 (pepsin digest 15% of total protein)
|
|
what secrets bicarbonate in the gut?
|
musocal cells (together with mucus) in stomach and duodenum;
stimulated by secretin |
|
What is the pathophys of cholera?
|
cholera toxin -> ADP-ribosylation of alpha-s subunit of GM1-ganglioside receptor of enterocyte luminal membrane (Gprotein R) -> const. active -> in. cAMP -> + anion secretion, - Na reabs -> diarrhea
(same for E.Coli heat-liable toxin) |
|
What is the pathophys of pertussis toxin
|
ADP ribosylate alpha-i subunit -> INACTIVATION of G-protein R -> cAMP+++ -> + anion secretion, - Na reabs -> diarrhea
|
|
What is guanylin? what bacterial toxin is implicated?
|
gut hormone, binds guanylin R on gut epithelium -> receptor guanylate cyclase -> GTP to cGMP -> + anion secretion, - Na reabs -> diarrhea
(same with E.Coli heat stable enterotoxin (STa) (NO stim. soluble GC) |
|
what is an effective treatment for bacterial diarrhea?
|
treat with nutrient (e.g. glucose, aa) + electrolyte + H2O
nut-coupled Na transport not dependent on cAMP or cGMP, not affected by cholera, pertussis or E.Coli toxins. |
|
what is the major transporter for acidic a.a. (glu, gln, asp)
|
none, used in energy metab as fuel for small intestine
|
|
what is the relationship between cholera and cystic fibrosis?
|
CF may give immunity to cholera & add + selection, cos CF has defective Cl- channels (targetted by cholera toxins)
|
|
how are peptides/aa taken up in jejunum?
|
as di/tri-peptides, cotransport with H+
|
|
how are peptides/aa taken up in ileum?
|
as single aa by membrane transporters, some Na-dep, some thru facilitated diffusion
|
|
how common is celiac disease?
|
~1 in 200 (atrophy of villi in prox. sm. bowel in rxn to gluten -> gliadin -> immune rxn)
|
|
what are the two sphincters for the esophagus?
|
1. cricopharyngeal sphincter
2. LES (lower eso sphnicter) |
|
muscle distribution in esophagus?
|
upper 1/3: striated
middle 1/3: mixed lower 1/3: smooth |
|
What happens when LES is too tight?
too loose? |
too tight: achalasia
too loose: reflux esophagitis |
|
what is the action of NO on the gut?
|
sm. mm. relaxation, e.g. relaxes LES
|
|
what two factors relaxes LES?
|
NO, VIP
|
|
what is receptive relaxation? what mediates it?
|
upper 1/3 of stomach (reservoir), on reception of food, relaxes, reg. by vagal n.
|
|
what is antral systole?
|
when food passes stomach antrum, increase pyloric sphincter tone (rigid but partially open) so that small food can pass, big food reflux back for further churning
|
|
where is iron reabsorbed in the gut?
|
in proximal duodenum
|
|
where is folate reabsorbed in the gut?
|
distal duodenum
|
|
where is B12 and bile salts reabsorbed in the gut?
|
distal ileum
|
|
where is short-chain fatty acids reabs in the gut?
|
cecum
|
|
(T/F) gut sm mm. myosin light chain needs phosphorylation to interact with actin to cause contraction
|
TRUE
|
|
what activates phosphorylation of myosin light chain in gut sm mm.?
|
Ca/Calmodulin -> activates MLC kinase -> P myosin light chain
|
|
what factors inhibit gastric emptying/acid secretion?
|
CCK, GIP, fat, secretin, VIP
|
|
what is the action of VIP and where is it secreted?
|
secreted by sm mm. and nerves of intestines;
relaxes intestinal sm mm, cause pancreatic HCO3 secretion and inhibits gastric H+, relaxes LES, cause vasodilation (secretalogue) |
|
what is the effect of parasympathetics (ACh)
|
inc. saliva, gastric H+, panc enz and HC03, simulates enteric nervous system to create intestinal peristalsis and relaxes sphincters.
|
|
what is the effect of sympathetics (NE)
|
inc. saliva, dec. splanchnic blood flow, motility, constricts sphincters
|
|
what is migrating motor complex (MMC)?
|
during fasting and b/w meals, ~90 min intervals, gut peristalsis to clear for the next meal (phase I: no spike; II: irreg spikes; III: reg spikes)
|
|
t/f. the MMC is regulated by vagus`
|
FALSE. it's autonomic
|
|
what is basic electrical rhythm?
|
pacemaker, not affected by hormones, baseline determining max freq of contractions, but does not determine actual contraction freq
|
|
t/f. basic electrical rhythm decreases from proximal to distal in small intestine, and inc. from prox to distal in colon
|
true
|
|
what stimulates MMC?
|
motilin, opioid, somatostatin
|
|
what inhibits MMC?
|
meal (gastrin, CCK)
|
|
what is spike potential?
|
on top of BER, affected by hormones and neurotransmitters, determines actual contraction of gut sm mm.
|
|
t/f. Symp (Epi/NE) stimulates spike potential; parasym (ACh) inhibits spike potential.
|
FALSE. reverse is true.
|
|
t/f. small bowel is leakier
|
true (prox to distal dec. in permeability)
|
|
what parasym plexus innervates the gut? symp?
|
parasymp: vagal and pelvic (distal colon and rectum)
symp:celiac, SM, IM |
|
what happens when LES is too loose? too tight?
|
reflux esophagitis; achalasia
|
|
what happens when antral systole is too loose? too tight?
|
dumping syndrome (vaso-vagal discharge with hypertension);
gastroparesis (usu. diabetic w/ neuropathy, impaired/no gastric motility and delayed emptying) |
|
describe the three phases of gastric digestion
|
cephalic phase, 30-40%, chewing etc -> vagus -> gastrin and H+
gastric phase, 50%, distension, luminal peptides/aa -> vagus -> gastrin/H+ intestinal phase: 10%, gastric chyme distention and aa -> acid |
|
describe the 3 phases of pancreatic exocrine digestion
|
1. cephalic: 50%, smell etc -> vagal -> ductular + acinar
2. gastric: distention, aa -> vagal -> gastrin -> acinar 3. intestinal: lum. fat (C18>12>8), gastric chyme -> CCK, secretin -> vagal -> acinar + ductular |
|
t/f. CCK acts via vagal stimulations
|
true
|
|
what't the major inhibitor of gastric acid secretion?
|
somatostatin
|
|
gastric luminal fat triggers production of what factors?
|
GIP, somatostatin, VIP
|
|
t/f. proton pumps in parietal cells are always present on apical side
|
false. they're stored in tubulovesicles at rest, and fuse with luminal membrane when stimulated
|
|
describe acid secretion in parietal cells
|
apical side:
H/K ATPase: H out, K in; K recycled out through: K/Cl channel H+ comes from H2CO3, which also gives HCO3-, which goes out through: basolateral side: HCO3-/Cl- antiporter |
|
what is omeprazole?
|
proton pump inhibitor
(subsituted benzimidazole: acid changes to sulfonamide (rxn w/ cysteine thiol groups) -> bind luminal domains of alpha unit of pump to inhibit ATPase) |
|
what receptors stimulate gastric acid secretion on basolateral side and give some antagonists.
|
histamine (cAMP): ranitidine, cimetidine, famotidine
ACh (PIP2): anticholinergics gastrin (PIP2): no clinically useful inhibitor prostaglandin: misoprostol (PGI2, PGE2 stimulates receptor) |
|
what are some remedies for stomach ulcer?
|
proton pump inhibitors
anti histamines anti cholinergics PG receptor antagonist (misoprostol) antacids and coating agents (sucralfate, CBS) |
|
what are the different cell types of gastric (oxyntic) gland?
|
surface/neck mucus cells (mucus, HCO3)
endocrine cells cheif cells (pepsinogen, gastric lipase) histamine mast cells (regulate pepsin and acid) pareital cells (HCl and IF) |
|
what factors stimulate chief cell pepsinogen release (pepsinogen granules on apical surface)
|
thru PIP2:
gastrin, CCK, GIP thru AC: secretin, VIP, PG(E), beta-agonist |
|
group the following:
trypsin, chymotrypsin, elastase, carboxypeptidase with: endopeptidase, exopeptidase, basic aa, aromatic aa, alipathic aa, C-term bonds |
endopep:
trypsin - basic chymo - aromatic elastase - alipathic exopep: carboxypeptidase - C-terminal bonds |
|
what different cell types are there in intestinal cells?
|
villus:
columlar polarized epi mucus/goblet cells crypt: mucosal endocrine Paneth cells -> defensin (anti microb) 3-5 days turnover from crypt to apoptosis at tip |
|
choose:
intestinal villus cells: BB hydrolase: high/low nut. trans.: high/low net absorption/secretion permeability: high/low do the same for crypt cells |
villus:
BB hydrolase: high nut. trans.: high net absorption permeability: low crypt: BB hydrolase: low nut. trans.: low net secretion permeability: high |
|
what increase aggressive factors for stomach ulcer?
|
(aggressive factors: acid, pepsin)
nicotin, gastric acid, NSAIDs, H pylori (cause inflammation, stimulate acid secretion) * H pylori survives stomach acid through urease H + NH3 -> NH4, buffer acidity |
|
what decrease protective factors for stomach ulcer?
|
(protective factors: mucus, bicarb)
NSAIDs (inhibits arachidonate, which inhibits mucus, HCO3, cos PGE&F stimulate mucus release), H pylori bile acids |
|
what are the different pancreatic enzymes?
|
alpha amylase
lipase, phospholipase A, colipase proteases (trypsin, chymotrypsin, elastase, carboxypeptidases) |
|
what converts trypsinogen to active trypsin?
|
enterokinase/enteropeptidase, a duodenal BB enzyme.
|
|
what activates zymogens of chymotrypsin, carboxypeptidases etc?
|
trypsin (trypsin also activates more trypsinogen)
|
|
wot common digestive problem do CF patients have?
|
panc insufficiency (thick mucus -> self digestion of panc by panc enzymes); malabsorption, steatorrhea (fatty stool), poor intake of fat-soluble vitamins
|
|
dorsal and ventral pancreas (development): which part is which?
|
body, tail, part head/uncinate: dorsum
part head/uncinate, bile duct: ventral (main conduit) |
|
what triggers zymogen granule release in acinar cells in pancreas?
|
thru IP3 -> NO -> cGMP -> PKs:
ACh (major), CCK, bombesin, substance P thru AC/cAMP-> PKs: secretin, VIP |
|
> how many grams of stool a day is considered diarrhea?
|
200g
|
|
sucrase and what is 1 gene, cleaved post-translationally?
|
isomaltase; cleaved by trypsin, but still non-covalently connected on BB membrane.
|
|
what glucose linkages do amylose and amylopectin have?
|
amylose: alpha 1-4 only
amylopectin: alpha 1-4 and 1-6 |
|
amylase digest what glucose linkage?
|
alpha 1-4, to give maltose, maltotriose, alpha-limit dextran (amylopectin)
|
|
in neonates, panc. amylase not well developed. what's important for digesting sugars?
|
salivary amylase
|
|
pancreatic amylase digests starch to what?
|
oligosaccharides, maltose, maltoriose
(only monosaccharides are absorbed) |
|
t/f. lactase drops to 10% neonatal amount by 5-10 years
|
true
|
|
oligosaccharide hydrolases are present where? include what?
|
at BB of intestine (rate-limiting step in carb digestion)
sucrase, lactase, trehalase (digest trehalose in mushrooms) |
|
how do the following enzymes break alpha-limit dextrans?
glucoamylase, isomaltase, sucrase |
glucoamylase: alpha 1-4
isomaltase: alpha 1-6 sucrase: maltose and maltosetriose to glucose |
|
jaundice results from what?
|
elevated bilirubin levels
|
|
what is bilirubin?
|
product of heme metabolism
|
|
match:
GLUT5, SGLT1, GLUT2 apical, basolateral, fructose, glucose, galactose, a.a. |
GLUT5: fructose, apical
SGLT1: glucose/Na+ symport, apical GLUT2: basolateral: fructose, galactose, glucose a.a. have their own Na-coupled transporter on apical side, and transporter on basolateral side. (3Na/2K ATPase on basolateral side to create gradient) |
|
what is kernicterus?
|
mother-fetus blood mismatch -> inc. hemolysis, inc. bilirubin -> jaundice
|
|
what is breast-milk jaundice?
|
in fetus, beta-glucoronidase deconj bili -> reabs for clearance by placenta. breast milk has glucoronidase
|
|
give the heme degradation pathway
|
in spleen:
heme -> (heme oxygenase) biliverdin -> (biliverdin reductase) bilirubin in liver (bound to cytosolic ligandin and Z-proteins after facilitated diffusion uptake) bilirubin conjugated to glucoronide (bilirubin UDP glucoronosyl-transferase) -> excreted into bile -> colon bact conversion to urobilinogen -> feces, or small fraction enterohepatic circulation or UB |
|
what happens to urobilinogen after enterohepatic circulation?
|
some re-excreted in bile, some renal excretion
urobilinogen -> (oxidation) urobilin (yellow colour in urine/stool) |
|
what are the properties of conj. vs unconj. bilirubin?
|
conj:
soluble, non-toxic, cannot be reabs in GI unconj: insoluble, reabs in GI, toxic, can cross BBB (esp in neonates where BBB is think) -> inhibits RNA syn and carb metab (neonatal kernicterus) |
|
with bile duct obstruction, can u detect urobilinogen in urine? in stool?
|
none in both.
(none in urine cos need to go through enterohepatic circulation (bilirubin converted to UB only in gut). bili in bile cannot flow to gut -> no UB made) |
|
with cholestasis, what becomes major site of clearnace for conjugated bilirubin? how?
|
kidneys.
unconj. bilirubin bound avidly to albumin, cannot be filtered out in kidneys. but some conj. bilirubin are not bound to albumin, and glom. filterated, but may form bilirubin gallstones. |
|
what causes conj. hyperbilirubinaemia? name two disorders
|
defect in cannicular transport
dublin johnson (pigment in hepatic lysosome) rotor's (no pigment) |
|
what causes unconj. hyperbilirubinemia?
|
inc. rbc hemolysis (mom-fetal incompatible); defective conjugation (e.g. def. bilirubin UDP glucoronyl transferase)
gilbert (partial UDPGT activity, benign until fasting/stressed) crigler-najjar syndrome: type I: complete loss -> death II: partial loss |
|
what are some therapeutic strategies for unconj. hyperbilirubinemia?
|
1. phenobartital -> inc. UDPGT
2. freq feeding (dec. enterohepatic circulation) 3. phototheraphy (inc. solubility of unconj. bili -> inc. excretion in urine) (esp in neonates cos small mass:surface ratio) 4. exchange fusion 5. bili binders (e.g. agar) |
|
what's phase I detoxification?
|
redox and hydrolysis:
make polar and soluble can make toxic intermediate P450-dep monooxygenase |
|
what is phase II detox?
|
conjugation:
inc. solubility: 1. glucoronide 2. sulfation dec. solubility: 3. methylation |
|
describe acetaminophen detox pathway
|
most: conj. to sulfate and glucoronate;
5-15%: P450-dep -> NAPQI -> conj to GSH -> mercapturic acid -> eliminate in kidneys NAPQI electrophilic, can rxt with sulfhydryl gps (covalent) -> necrosis (happens when GSH is depleted) |
|
why are alcoholics more susceptible to acetaminophen toxicity?
|
alcoholics:
1. induction of P450 (makes more NAPQI) 2. depletion of GSH (cannot conj NAPQI to make mercapturic acid for elim in kidneys) |
|
how do you treat acetaminophen toxicity?
|
treat with N-acetyl-cystein, which is a precursor for GSH -> inc. conj. of NAPQI.
|
|
how do you treat patients with mutated MTTP (microsomal triglycerides transport protein)?
|
no MTTP: cannot take up fatty acids on basolateral side.
can give medium-chain TG (hydrolysed by lipase more rapidly and more soluble, diffuse directly across lumenal cells into portal blood) |
|
how are long-chain triglycerides digested and absorbed?
|
lumen:
emulsify -> lipolysis (lipases) -> solubilize -> diffuse musocal: 1. uptake (binding proteins for free f.a. and 2-monoglycerides) 2. transport to smooth ER 3. TG resynthesis from f.a. 4. package into chylomicrons (MTTP-dep) 5. export chylo to lymphatics on basolateral side (MTTP-dep) *MTTP = microsomal TG transport protein |
|
what protein do you test for general liver function?
|
albumin (55-60% of all plasma protein), made by liver, hydrophilic, bind and transport hydrophobic proteins
|
|
how is liver portal venous pressure measured?
|
indirectly by wedged hepatic VP;
hep. VP gradient = WHVP - free HVP (or IVC pressure) normal should be low since hep. portal venous blood flow is very low and constant |
|
what are the values of HVPG and PVP for portal hypertension
|
normal hep. venous pressure gradient (=WHVP - free HVP/IVC P) should be very low (since blood flow in portal system is low and constant)
portal HT: > 5 mmHg HVPG or > 12 mmHg portal venous pressure (measured by wedged hep. VP) |
|
t/f. inc. portal vascular resistance or inc. inflow -> portal hypertension
|
true
|
|
what are the different types of portal hypertension?
|
prehepatic (e.g. portal vein thrombosis)
intrahepatic (e.g. cirrhosis) post hepatic (e.g. IVC obstruction) |
|
what happens to blood vessels in the portal system when there is portal hypertension?
|
portosystemic collaterals form (eso, abd, stomach, periumbillical area, rectum) -> variceal bleeding
|
|
what are the complications of portal HT?
|
1. splenomegaly and hypersplenism -> sequestration of rbc, wbc and platelets -> low platelet count
2. variceal bleeding 3. heptaic encephalopathy (cos build up ammonia -> CSF glutamine, also trp metab and GABA-like stuff) 4. ascites (liver and intestinal lymph), favored by hypoalbuminemia (often in cirrhosis) |
|
what are the characteristics of liver cirrhosis?
|
1. collagen deposition
2. inc. cell dize 3. regenerative nodules 4. contraction of myofibroblasts |
|
where is ammonia metabolized? what is it metabolized to? why is it toxic?
|
in liver, to urea (mainly from glutamate).
NH3 can cross BBB, esp toxic to glial cells |
|
t/f liver uses mainly carbs as fuel
|
false: prefers fatty acids.
|
|
what is the pathology of CF? what are the related symptoms?
|
defective Cl- channel, thick mucus, high Cl- in sweat, intestinal obstruction, panc duct blocked, acinar cells atrophy/self-destruction, poor digestion, lung infections
|
|
what is diabetic diarrhea?
|
adrenergic neuropathy due to reduced blood flow -> inc. anion secretion and reduced Na reabsorption
|
|
how do u treat diabetic diarrhea?
|
treat with alpha2 adrenergic R agonist (e.g. clonidine) or Octreotide (somatostatin analog, stim. net absorption)
|
|
what is celiac disease?
|
autoimmune rxn to gliadin (short peptide undigestable from gluten_ -> villi atrophy -> dec. CCK, gastrin, secretin
|
|
what is increased urine amylase diagnostic of?
|
pancreatitis
|
|
mix and match:
hartnup's disease, cystinuria, lysinuric proterin intolerance. dibasic a.a., cationic a.a. , neutral a.a.,(basolateral or lumenal?) |
hartnup's: neutral a.a. on lumenal
cystinuria: dibasic a.a. on lumenal (Cys, Ornithine, Lys, Arg (COLA) lysinuric PI: cationic a.a. on basolateral (OLA) |
|
excess cystein from cystinuria can result in what? treat with what?
|
kidney stones. treat with acetazolamide to alkalize urine
|
|
what is more severe? cystinuria, hartnup's or lysinuric prot. intolerence?
|
lysinuric protein intolerance (def transport for cationic aa (lys, arg, orn) at basolateral side. (for the other two, def. lumenal transporters,but di/tri-peptides can be taken up and broken down intracellularly and transported through basolateral transporters, mutated in LPI)
|
|
what are the effects of increased short-chain fatty acids (diet carb digested by colon flora and bact)
|
inc. NHE
preferred fuel for colonocytes inc. mucosal proliferation inc. Na abs |
|
t/f
inc aldosterone leads to: prox colon: inc. Na pump/ PD-dep Na channel distal colon: inc. NHE |
false, reverse
|
|
what is the compensatory mech for small bowel resection or disease?
|
inc. villi width and height, inc. Na abs by inc. NHE
|
|
diff. bile acid-dep flow vs b.a.-indep flow (both -> canalicular)
|
b.a.-dep: active trans of b.a., electrolytes follow;
indep: active trans of electrolytes --> canalicular, rate limiting |
|
what are the components of bile acid secretion?
|
bile acid-dep flow, bile acid-indep flow -> canalicular;
ductular secretion (stim. by secretin via cAMP): 1. inc. Cl-/HCO3- -> lumen neg and alkaline -> Na and H20 outflow 2. Cl- channel open to fill lumen with Cl- |
|
give examples of bile acids metabolism disorders (reasons for inadequate b.a. for digestion of fat)
|
1. cholestasis (bile flow failure)
2. ileal resection 3. bact outgrowth (decong. -> readily reabs b.a. -> dec. in gut -> malabs and toxi decong. b.a.) |
|
t/f
f.a. absorption: rate limiting = diffusion of micelles thru "unstirred H20 layer" |
true. (lower pH near plasma membrane -> f.a. protonated -> more soluble)
|
|
what converts cholecterol to bile salts?
|
7alpha hydroxylase (rate limiting, bile salts feedback inhibit both 7a and HMG CoA reductase)
|
|
dietary fat absorption is ?% efficient?
|
95% !!!
|
|
bile acids conjugated to __ and __ to make them charged to increase solubility?
|
taurine and glycine
|
|
liver lobule vs hepatic acinus
|
lobule: central vein in center, triad at corner (hep artery, portal vein, bile duct)
acinus: triad at center, zone 1-3, 1 most regen and resistant to hypoxia |
|
what's the main function of gall bladder?
|
store and concentrate bile (by extracting water)
|
|
what is primary vs secondary bile salts?
|
primary: cholate and chenodeoxycholate
secondary: after bacterial deconj. (-> primary via reabs, reconj. in liver) -> tertiary ursodeoxycholate (more soluble, used as med to inc. bile flow for ppl with small stone) |
|
where and how is bile reabs?
|
>90% reabs via apical Na-dep bile transporter (ASBT) in ielum
|
|
what are the 3 different types of lipases?
|
sepcific for TG
1. gastric (hydrolyse f.a. at 3 position) 2. panc (hydrolyse at 1 and 3 position) also for acylglycerols, chol esters, vit esters, phospholipids: 3. bile-salt activated, made by panc (e.g. phospholipase A2, chol esterase) |
|
t/f
gastric lipase requires co-lipase but panc lipases do not |
false. panc lipase requires co-lipase, which binds and displace bile salts coating surface of oil droplets, which inhibit binding of panc lipase
|
|
t/f
panc lipase is at large excess, >90% must be lost before u see fatty stool |
true
|